Skip to main content

Table 6 West Java originated HLA-DRB1 binding sites of highly antigenic peptides

From: In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45

Peptides

Positions

HLA-2 binding alleles

VaxiJen scores

GLRRRPTIGPRKR

503–515

HLA-DRB1*04:02

2.0738

AGLRRRPTIGPRKR

502–515

HLA-DRB1*04:02

2.0411

LRRRPTIGPRKRP

504–516

HLA-DRB1*04:02

1.9788

VQAGLRRRPTIGPRKR

500–515

HLA-DRB1*04:02

1.8995

GLRRRPTIGPRKRP

503–516

HLA-DRB1*04:02

1.8611

AGLRRRPTIGPRKRP

502–516

HLA-DRB1*04:02

1.8494

VQAGLRRRPTIGPR

500–513

HLA-DRB1*04:02

1.8122

QAGLRRRPTIGPRKR

501–515

HLA-DRB1*04:02

1.8078

LRRRPTIGPRKRPA

504–517

HLA-DRB1*04:02

1.7785

AGLRRRPTIGPRK

502–514

HLA-DRB1*04:02

1.7631

AGLRRRPTIGPRKRPA

502–517

HLA-DRB1*04:02

1.6938

QAGLRRRPTIGPR

501–513

HLA-DRB1*04:02

1.6929

GLRRRPTIGPRKRPA

503–517

HLA-DRB1*04:02

1.6909

LRRRPTIGPRKRPAA

504–518

HLA-DRB1*04:02

1.6606

VQAGLRRRPTIGPRK

500–514

HLA-DRB1*04:02

1.6539

QAGLRRRPTIGPRKRP

501–516

HLA-DRB1*04:02

1.6522

GLRRRPTIGPRKRPAA

503–518

HLA-DRB1*04:02

1.5902

VQAGLRRRPTIGP

500–512

HLA-DRB1*04:02

1.5776

LVQAGLRRRPTIGPR

499–513

HLA-DRB1*04:02

1.5675

QAGLRRRPTIGPRK

501–514

HLA-DRB1*04:02

1.5305

LRRRPTIGPRKRPAAS

504–519

HLA-DRB1*04:02

1.5179

FLVQAGLRRRPTIGPR

498–513

HLA-DRB1*04:02

1.4645

LVQAGLRRRPTIGPRK

499–514

HLA-DRB1*04:02

1.441

LVQAGLRRRPTIGP

499–512

HLA-DRB1*04:02

1.3345

FLVQAGLRRRPTIGP

498–512

HLA-DRB1*04:02

1.244

  1. The peptide core is shown in bold